Godeberge P. Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo.
Angiology. 1994;45:574 - 578.
Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.
Angiology. 1994;45:566 - 573.
Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids.
Br J Surg. 2000;87:868 - 872.
Ho YH, Tan M, Seow-Choen F. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial.
Dis Colon Rectum. 2000;43:66 - 69.
Thanapongsathorn W, Vajrabukka T. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids.
Dis Colon Rectum. 1992;35:1085 - 1088.
Wijayanegara H, Mose JC, Achmad L, et al. A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy.
J Int Med Res. 1992;20:54 - 60.
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs. 1992;44:1013 - 1032.
Saggioro A, Chiozzini G, Pallini P, et al. Treatment of hemorrhoidal crisis with mesoglycan sulfate [in Italian; English abstract].
Minerva Dietol Gastroenterol. 1985;31:311 - 315.
Saggioro A, Chiozzini G. Mesoglycan sulfate in acute hemorrhoidal pathology [in Italian; English abstract].
Villalba G. Anthocyanosides as a new vasculotrophic agent in patients with hemorrhoids.
Medicina (Mex). 1974;54:73 - 76.